Bulletin
Investor Alert

New York Markets Close in:

Medexus Pharmaceuticals Inc.

TSE: CA:MDP

GO

Quotes are delayed by 15 min

Feb 1, 2023, 11:00 a.m.

MDP
/zigman2/quotes/208555543/delayed

$

1.86

Change

-0.04 -2.11%

Volume

Volume 3,756

Quotes are delayed by 15 min

/zigman2/quotes/208555543/delayed

Previous close

$ 1.90

$ 1.86

Change

-0.04 -2.11%

Day low

Day high

$1.84

$1.89

Open

52 week low

52 week high

$0.88

$3.45

Open

Michael Peter Mueller

Michael Peter Mueller is a businessperson who has been at the head of 9 different companies and currently holds the position of Independent Chairman at Laurentian Bank of Canada and Chairman for Laurentian Bank Financial Group (a subsidiary of Laurentian Bank of Canada) and Chairman at Revera, Inc. (Canada). He is also on the board of 5 other companies.

In the past Mr. Mueller was Director at The Scarborough Hospital, Chairman of Annidis Corp., Chairman at Eureka 93, Inc. and Director at Mercal Capital Corp. (a subsidiary of Eureka 93, Inc.), Vice Chairman & Head-Global Investment Banking at The Toronto-Dominion Bank, Chairman of The Public Sector Pension Investment Board and President, Chief Executive Officer & Director at Lumira Capital Investment Management, Inc.

Mr. Mueller received an undergraduate degree from the University of Western Ontario and an MBA from York University.

Transactions

Date Shares Transaction Value
12/20/2022 3,028   0
11/18/2022 24,595   0
02/23/2021 11,200   75,376
09/10/2019 500   1,875
09/10/2019 500   1,880
12/19/2018 23,333   0
12/19/2018 452,977   0
12/12/2018 100,000   0

Officers and Executives

Mr. Kenneth d’Entremont
Chief Executive Officer & Director
Mr. Richard Labelle
VP-Allergy, Pediatric & OTC Portfolios
Mr. Marcel Konrad
Chief Financial Officer
Mr. Ian C. Wildgoose Brown
Secretary & General Counsel
Mr. Peter A. van der Velden
Chairman
Ms. Adele M. Gulfo
Independent Director
Mr. Michael Peter Mueller
Independent Director
Mr. Benoit Gravel
Independent Director
Mr. Stephen Nelson
Independent Director
Link to MarketWatch's Slice.